A detailed history of Allen Capital Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Allen Capital Group, LLC holds 113,921 shares of PFE stock, worth $2.96 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
113,921
Previous 104,375 9.15%
Holding current value
$2.96 Million
Previous $2.92 Million 12.88%
% of portfolio
0.39%
Previous 0.38%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $264,424 - $299,648
9,546 Added 9.15%
113,921 $3.3 Million
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $14,802 - $17,345
586 Added 0.56%
104,375 $2.92 Million
Q1 2024

Apr 15, 2024

SELL
$25.89 - $29.73 $102,757 - $117,998
-3,969 Reduced 3.68%
103,789 $2.88 Million
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $1.05 Million - $1.36 Million
40,145 Added 59.37%
107,758 $3.1 Million
Q3 2023

Nov 01, 2023

BUY
$32.09 - $37.51 $65,014 - $75,995
2,026 Added 3.09%
67,613 $2.24 Million
Q2 2023

Jul 24, 2023

BUY
$36.12 - $41.79 $150,403 - $174,013
4,164 Added 6.78%
65,587 $2.41 Million
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $2.42 Million - $3.15 Million
61,423 New
61,423 $2.51 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $91,283 - $111,434
2,086 Added 5.0%
43,825 $1.92 Million
Q2 2022

Jul 27, 2022

BUY
$46.53 - $55.17 $36,991 - $43,860
795 Added 1.94%
41,739 $2.19 Million
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $61,808 - $76,588
1,351 Added 3.41%
40,944 $2.12 Million
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $1.64 Million - $2.43 Million
39,593 New
39,593 $2.34 Million
Q4 2021

Jan 25, 2022

SELL
$41.32 - $61.25 $1.63 Million - $2.41 Million
-39,421 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$39.25 - $50.42 $41,762 - $53,646
1,064 Added 2.77%
39,421 $1.7 Million
Q2 2021

Jul 20, 2021

BUY
$35.91 - $40.68 $358,166 - $405,742
9,974 Added 35.14%
38,357 $1.5 Million
Q1 2021

Apr 29, 2021

BUY
$33.49 - $37.77 $215,139 - $242,634
6,424 Added 29.25%
28,383 $1.03 Million
Q4 2020

Jan 19, 2021

BUY
$33.47 - $42.56 $64,864 - $82,481
1,938 Added 9.68%
21,959 $808,000
Q3 2020

Oct 20, 2020

SELL
$31.75 - $37.25 $3,841 - $4,507
-121 Reduced 0.6%
20,021 $697,000
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $606,677 - $735,988
20,142 New
20,142 $659,000
Q1 2019

Apr 30, 2019

SELL
$37.5 - $41.2 $383,025 - $420,816
-10,214 Closed
0 $0
Q4 2018

Jan 29, 2019

BUY
$38.47 - $43.86 $120,218 - $137,062
3,125 Added 44.08%
10,214 $434,000
Q3 2018

Oct 22, 2018

BUY
$34.47 - $41.81 $30,402 - $36,876
882 Added 14.21%
7,089 $312,000
Q2 2018

Jul 27, 2018

SELL
$32.98 - $35.16 $68,400 - $72,921
-2,074 Reduced 25.05%
6,207 $225,000
Q1 2018

May 01, 2018

BUY
$31.91 - $37.02 $264,246 - $306,562
8,281 New
8,281 $294,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Allen Capital Group, LLC Portfolio

Follow Allen Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Capital Group, LLC with notifications on news.